ACB vs CRON: stock comparison and AI forecast
Aurora Cannabis Inc (ACB) and Cronos Group Inc. (CRON) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACB Aurora Cannabis Inc
- Market Cap
- $332M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
CRON Cronos Group Inc.
- Price
- $3.61 +40.5% · 6M
- Market Cap
- $1.33B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CRON is 4.0 times larger than ACB by market capitalization ($1.33B against $332M).
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACB | CRON |
|---|---|---|
| Market Cap | $332M | $1.33B |
| P/B Ratio | – | 1.24x |
| EPS | $-7.26 | $-0.05 |
| Book Value/Share | – | $2.91 |
| Revenue/Share | $10.46 | $0.74 |
| FCF/Share | – | $0.18 |
Profitability & Margins
| Metric | ACB | CRON |
|---|---|---|
| ROIC | – | 0.6% |
| Gross Margin | 37.0% | 35.3% |
| Operating Margin | -46.8% | 2.6% |
| EBT Margin | -215.2% | 22.1% |
| Tax Rate | 0.7% | -14.2% |
Financial Health
| Metric | ACB | CRON |
|---|---|---|
| Current Ratio | – | 12.71x |
| Quick Ratio | – | 11.91x |
| D/E Ratio | – | 0.07x |
| Financial Leverage | – | 1.12x |
| Interest Coverage | – | 42.0x |
| Working Capital | – | $792M |
Cash Flow
| Metric | ACB | CRON |
|---|---|---|
| Operating Cash Flow | -$200M | $81M |
| Free Cash Flow | – | $65M |
| Capital Spending | – | -$16M |
| OCF Growth YoY | – | 272.8% |
| FCF/Sales | – | 24.1% |
| CapEx/Sales | – | 5.8% |
Operational Efficiency
| Metric | ACB | CRON |
|---|---|---|
| Asset Turnover | – | 0.23x |
| Receivables Turnover | – | 6.2x |
| Fixed Assets Turnover | – | 1.9x |
| Days Sales Outstanding | – | 59 days |
Income Statement
| Metric | ACB | CRON |
|---|---|---|
| Total Revenue | $662M | $272M |
| Operating Income | -$310M | $7M |
| R&D Expense | $16M | $5M |
| SG&A Expense | – | $85M |
Dividend & Shareholder Information
| Metric | ACB | CRON |
|---|---|---|
| Shares Outstanding | 63M | 368M |
| EPS Growth | – | -131.2% |
ACB vs CRON: stock comparison and AI forecast
Which is bigger, ACB or CRON?
CRON is 4.0 times larger than ACB by market capitalization ($1.33B against $332M).
Which one does Intratio's AI model rank higher, ACB or CRON?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.